Taking hydroxychloroquine shortly after being exposed to the new coronavirus does not, a priori, prevent an infection, researchers reported on Wednesday following a clinical trial. The drug was touted by Donald Trump.
The President has announced that he is using it as a means of prevention against coronavirus disease 2019 (Covid-19). But a study of 821 people in the United States and Canada found that it was not much more effective than a placebo for this purpose.
Used for a long time against malaria, hydroxychloroquine, whose effectiveness against Covid-19 has never been rigorously demonstrated, unleashes passions.
A team of scientists led by the University of Minnesota selected adults who had been in contact with a person who tested positive for coronavirus for more than 10 minutes at a distance of two meters or less. The majority of them were considered to be ‘at risk’ of being infected, because they did not wear a mask or eye protection when interacting with the infected person.
12% had coronavirus
All randomly received either hydroxychloroquine or a placebo within four days of contact. The researchers then analyzed through laboratory tests and the study of symptoms how many of them contracted Covid-19 in the following two weeks.
‘This randomized trial did not demonstrate a significant benefit of hydroxychloroquine as a prophylactic treatment after exposure to Covid-19’, concluded the authors.
49 of the 414 patients (12%) who received the treatment contracted the disease, compared to 58 of the 407 (14%) who received a placebo, a difference not considered statistically significant. Side effects were more common with hydroxychloroquine than with placebo, but in both cases they were not undesirable.
The results of the study were eagerly awaited, as it was a randomized controlled trial, an experience which is considered the benchmark for the study of clinical outcomes.
Despite everything, ‘the study is too small to be irrefutable,’ warns Martin Landray, a professor of medicine and epidemiology at the University of Oxford, who did not participate in the preparation of the study. More studies will be needed to know for sure whether or not hydroxychloroquine can have a moderate positive effect, the expert believes.
/ ATS
– .
